No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
IGM Biosciences' Insiders' Timely Sale May Have Helped Mitigate 10% Dip in Share Price
IGM Biosciences Initiated at Outperform by BMO Capital
BMO Capital Initiates IGM Biosciences(IGMS.US) With Buy Rating, Announces Target Price $21
Stifel Maintains IGM Biosciences(IGMS.US) With Buy Rating, Raises Target Price to $27
Express News | IGM Biosciences Inc : Stifel Raises Target Price to $27 From $25
RBC Capital Reaffirms Their Buy Rating on IGM Biosciences (IGMS)
No Data